NCT03376386View on ClinicalTrials.gov

Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 21, 2017

Primary Completion Date

April 25, 2019

Study Completion Date

April 25, 2019

Conditions
Head and Neck Cancer
Interventions
RADIATION

Adaptive dose-Escalated multi-modality image-guided radiotherapy

FDG-PET/CT-scan will be used twice during radiotherapy for a mild dose-escalation to the less-responding parts of the tumor. By adapting the radiotherapy plan, these areas will receive 74-78 Gy.

Trial Locations (1)

1066CX

Netherlands Cancer Institute, Amsterdam

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER

NCT03376386 - Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy | Biotech Hunter | Biotech Hunter